ABSTRACT NUMBER: ESOC2026A1385 CONSERVATIVE VS AGGRESSIVE ANTIPLATELET STRATEGY FOR EMERGENT CAROTID STENTING DURING STROKE THROMBECTOMY: A PATIENT LEVEL META-ANALYSIS WITH META-REGRESSION
Amr Elrosasy, Obai Yousef · 2026
Read ABSTRACT NUMBER: ESOC2026A1385 CONSERVATIVE VS AGGRESSIVE ANTIPLATELET STRATEGY FOR EMERGENT CAROTID STENTING DURING STROKE THROMBECTOMY: A PATIENT LEVEL META-ANALYSIS WITH META-REGRESSION by Amr Elrosasy, Obai Yousef (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146680.txt.
Description
Amr Elrosasy and Obai Yousef report a 2026 conference review comparing strong versus mild clot drug care when a neck vessel stent is placed during stroke treatment. Two blockages at once force a hard trade-off. Stronger drugs keep the stent open but may raise bleeding risk in the brain.
Pooling patient-level data from past studies, the pair found strong drug care kept stents open on day one far more often. Gains in blood flow, function, and survival all leaned toward strong care but stayed too weak to call firm. Bleeding rates did not split clearly either. The authors say larger studies are needed before a firm rule can be set.
Catalog record
| CREATOR | Amr Elrosasy, Obai Yousef |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |